4th Annual Biomarkers - CDx - Precision Immunotherapy Summit
04-05

October 2018

Austria

Vienna

Hilton Garden Inn Vienna South

Hertha-Firnberg-Straße 5, 1100

Co-located with Immuno-Oncology & Microbiome

We are pleased to invite you to the 4th Annual Biomarkers - CDx - Precision Immunotherapy Summit scheduled for October 4th - 5th, 2018 in Vienna, Austria. This Summit is co-located with Immuno-Oncology & 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summits. The co-located Summits will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Biomarkers, Precision Medicine, Companion Dx, Immuno-Oncology and Microbiome, and will shed the light...

We are pleased to invite you to the 4th Annual Biomarkers - CDx - Precision Immunotherapy Summit scheduled for October 4th - 5th, 2018 in Vienna, Austria. This Summit is co-located with Immuno-Oncology & 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summits. The co-located Summits will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Biomarkers, Precision Medicine, Companion Dx, Immuno-Oncology and Microbiome, and will shed the light on the latest advancements and improvements in research and development, business opportunities in partnering, and investment. We will discuss key findings, critical insights, as well as recommendations for accelerating development in the field. We are excited to be hosting these Summits in Vienna and we look forward to welcoming you in October.

more info
Who Should Attend

Chief Executives, Vice Presidents, Directors, Department Heads, Leaders, and Managers specialising in:

  • Companion Diagnostics
  • Personalised Healthcare
  • Medical Sciences
  • Translational Medicine
  • Clinical Trials
  • Commercialisation
  • Payers
  • Insurers
  • Immunology
  • Non-oncology
  • Drug Development
  • Molecular Diagnostics
  • Biomarkers
  • Experimental Medicine
  • Clinical Development
  • Regulatory
  • Market Access
  • Patient Advocates
  • Genomics
  • Oncology
  • Rare Diseases
  • Research
Key Practical Learning Points of the Summit

Clinical & translational biomarkers in oncology and beyond
CDx development & regulatory
Dx market access, reimbursement, commercialization, partnerships
Precision Dx & personalized immunotherapy
Speakers
Dr. Frédéric Baribaud, US

Scientific Director

Janssen R&D

Dr. Rajiv Raja, US

Director / Translational Medicine & Pharmacogenomics

MedImmune / AstraZeneca

Dr. David Chafin, US

Principal Scientist / Roche Tissue Diagnostics

Ventana Medical Systems, Inc.

Francesca Rossi, IT

Director, Worldwide Regulatory Strategy- Oncology

Pfizer

Dr. Alix Berton, SE

Associate Director, Clinical Development & Diagnostic Expert

AstraZeneca

Dr. Ralph Graeser, DE

Senior Translational Medicine Expert

Boehringer Ingelheim Pharma GmbH & Co. KG

Dr. George Lee, US

Digital Pathology Informatics Lead, Translational Medicine

Bristol-Myers Squibb

Dr. Josef Straub, DE

Associate Director Clinical Biomarkers & Companion Diagnostics / R&D | Global Early Development

Merck KGaA

Dr. Jonathan Frampton, UK

Strategic Alliances (Diagnostics)

Horizon Discovery Ltd.

Dr. Svetlana Mukhina, DE

Manager Global Regulatory Affairs, Biomarkers & Diagnostics

Merck KGaA, Germany

Dr. Karine Sargsyan, AT

Chief Operating Officer

Biobank Graz, Medical University of Graz

Christopher Levis, US

Business Development Manager

Thermo Fisher Scientific

Prof. Dr. med. Dr. h.c. Manfred Dietel, DE

Fm. Director of the Institute of Pathology

University Hospital Charité

Dr. Christophe le Tourneau, FR

Senior Medical Oncologist & Professor of Medicine

Institut Curie & Versailles-Saint-Quentin- en-Yvelines University

Dr. Thomas Hach, CH

Director Healthcare Systems

Novartis International AG

Christa Noehammer, AT

Senior Scientist

AIT Austrian Institute of Technology GmbH

Peter Bogaert, BE

Partner

Covington & Burling LLP

Annual

Events

Previous Year Attendees
  • Diaxonhit

    CEO & President

  • Healthcare Strategies

    Founder

  • Astrazeneca

    Executive Director & Lead of companion diagnostics

  • Leica Biosystems

    Vice President

  • Biocartis

    VP of Business Development

  • Almac

    VP, Bioinformatics and Biostatistics

  • Sysmex Inostics GmbH

    Director of Pharmaceutical Sales & Technology

  • Roche

    Vice President, Clinical Operations

  • Roche

    VP International Business Leader – CDx

  • R-Biopharm AG, Darmstadt

    Vice President Companion Diagnostics

  • Integrated Medicines Ltd

    Managing Director

  • Hologic

    Molecular Genetic Services Manager

  • Glyconics Limited

    Chief Executive Officer

  • Agilent Technologies

    Global Commercial Director CDx

  • Merck KGaA

    Associate Director - Global Business Development

  • Randox Laboratories

    Head of Biomarker Services - Biosciences

  • Randox Laboratories

    Marketing Manager -Biosciences

  • Randox Laboratories

    Project Manager

  • Medac GmbH

    Director of Companion Diagnostics

  • Medac GmbH

    Global Portfolio & Alliance Manager

  • IMMUDEX

    CEO

  • IMMUDEX

    COO

  • Atlas Genetics Ltd.

    R&D Director

  • Siemens Healthcare

    Head of Global & Scientific Marketing

  • Crown Bioscience Inc.

    Director of Marketing

  • Tecan Trading AG

    Head Market Development

  • ImmunID

    CEO

  • Thermo Fisher Scientific

    Director, Business Development Diagnostics Partnering

  • Exosome Diagnostics GmbH

    Vice President Product Development

  • Pierre Fabre

    Project Leader

  • Farmavita Regulanet d.o.o

    Media Partner / Managing Director

  • WiCON

    Media Partner / China Representative

  • Medix Biochemica

    R&D Manager, Diagnostics tests

  • Biotype Innovation GmbH

    General Manager

  • Humedics GmbH

    CEO

  • Novacyt S.A.

    Sales & Marketing Manager

  • Centogene AG

    CEO

  • Centogene AG

    Senior Director of Quality Management

  • bioMérieux

    R&D director

  • Glycotope GmbH

    Manager Preclinical Pharmacology&ADG

  • Molecular Health GmbH

    Key Account Manager Kliniken Clinics/Onco

  • Genefron Ltd

    CEO

  • Roche Diagnostics International

    Life Science Alliances

  • Roche Diagnostics GmbH

    Life Science Alliance EMEA/LATAM

  • Pierre Fabre Pharmaceuticals

    VP Translational Medicine

  • Roche Diagnostics

    International Product Manager Companion Diagnostics

  • Thermo Fisher Scientific

    Director, Business Development Diagnostics Partnering

  • Sysmex Inostics

    VP & Managing Director, Global Commercial Operations

  • R-Biopharm AG

    Director Early Development Companion Diagnostics

  • Sophia Genetics

    VP Business Development

  • Sophia Genetics

    Sales & Business Development Manager Pharma Markets

  • Merck

    Associate Director, Global Regulatory Affairs Companion Diagnostics

  • Teva Pharmaceuticals

    Global Head, Diagnostics & Personalized Medicine

  • QIAGEN

    Director Companion Diagnostic Commercialization

  • Siemens Healthineers

    Director Business Development Molecular Services

  • Horizon Discovery Ltd

    Associate Director Business Development, Diagnostics

  • Hologic

    Biomarker Services Manager

  • Integrated Medicines Ltd,

    Managing Director

  • numares AG

    President & Chief Operating Officer

  • numares AG

    Marketing Manager

  • Medac

    Director Companion Diagnostics

  • Boehringer-ingelheim

    Project Leader R&D

  • Roche

    Head of Licenzing and Senior Director of CDx

  • Interlux

    Application Specialist

  • Thermo Fisher Scientific

    Head of Bussines Development

  • Thermo Fisher Scientific

    Associate Director

  • Alere

    EME Marketing Director - Infectious disease

  • GANYMED Pharmaceuticals AG

    Regulatory Affairs Manager

  • Oxford Biodynamics

    Chief Scientific Officer

  • Oxford Biodynamics

    Business Development Director

  • Helsinn Healthcare

    Dep.Director

  • MDQuest LTD

    CEO, Business Development Consultant

  • Sanquin

    Business Development Manager

  • Sanquin

    Head of Marketing

  • Illumina

    Director, Business Development

  • Bio-Rad

    Marketing Workflow Manager Genomics

  • Bio-Rad

    Marketing Manager

  • Biontech AG

    Director, Business Development

  • Sysmex Inostics GmbH

    Pharma Key Account Manager Europe

  • Sysmex Inostics GmbH

    Senior Product Manager

  • Roche

    International Manager Life Science Alliances EMEA-LATAM

  • Medixbiochemica

    R&D Manager, Diagnostics tests

  • AgPlus Diagnostics Ltd

    Business Development Manager

  • LEO-Pharma

    Senior Project Manager Research Projects

  • Abcam

    Vice President, Diagnostics and Licencing

  • Sanofi

    Global Head of Translational Medicine Early Development



more info
Sponsors and Partners

Partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner